Back to search results

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Little Rock, Arkansas, United States

  • Research Site, Los Angeles, California, United States

  • Research Site, Oakland, California, United States

  • Research Site, New Haven, Connecticut, United States

  • Research Site, Stuart, Florida, United States

  • Research Site, Gainesville, Georgia, United States

  • Research Site, Chicago, Illinois, United States

  • Research Site, Baltimore, Maryland, United States

  • Research Site, Baltimore, Maryland, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, Saint Louis Park, Minnesota, United States

  • Research Site, Omaha, Nebraska, United States

  • Research Site, Buffalo, New York, United States

  • Research Site, Cleveland, Ohio, United States

  • Research Site, Pittsburgh, Pennsylvania, United States

  • Research Site, Chattanooga, Tennessee, United States

  • Research Site, Memphis, Tennessee, United States

  • Research Site, Nashville, Tennessee, United States

  • Research Site, Nashville, Tennessee, United States

  • Research Site, Nashville, Tennessee, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Houston, Texas, United States

  • Research Site, Fairfax, Virginia, United States

  • Research Site, Edmonds, Washington, United States

  • Research Site, Seattle, Washington, United States

  • Research Site, Ghent, Belgium

  • Research Site, Ghent, Belgium

  • Research Site, Roeselare, Belgium

  • Research Site, Edmonton, Alberta, Canada

  • Research Site, Winnipeg, Manitoba, Canada

  • Research Site, Montreal, Quebec, Canada

  • Research Site, Montreal, Quebec, Canada

  • Research Site, Avignon, France

  • Research Site, Bobigny, France

  • Research Site, Bordeaux, France

  • Research Site, Limoges, France

  • Research Site, Rennes, France

  • Research Site, Rouen, France

  • Research Site, Suresnes, France

  • Research Site, Toulon, France

  • Research Site, Kecskemét, Hungary

  • Research Site, Székesfehérvár, Hungary

  • Research Site, Tatabánya, Hungary

  • Research Site, Törökbálint, Hungary

  • Research Site, Dublin, Ireland

  • Research Site, Dublin, Ireland

  • Research Site, Dublin, Ireland

  • Research Site, Galway, Ireland

  • Research Site, Aviano, Italy

  • Research Site, Brescia, Italy

  • Research Site, Catanzaro, Italy

  • Research Site, Florence, Italy

  • Research Site, Genova, Italy

  • Research Site, Meldola, Italy

  • Research Site, Milan, Italy

  • Research Site, Monza, Italy

  • Research Site, Padova, Italy

  • Research Site, Perugia, Italy

  • Research Site, Pisa, Italy

  • Research Site, Roma, Italy

  • Research Site, Rozzano, Italy

  • Research Site, Lisbon, Portugal

  • Research Site, Lisbon, Portugal

  • Research Site, Lisbon, Portugal

  • Research Site, Lisbon, Portugal

  • Research Site, Porto, Portugal

  • Research Site, Porto, Portugal

  • Research Site, Porto, Portugal

  • Research Site, Busan, South Korea

  • Research Site, Chungcheongbuk-do, South Korea

  • Research Site, Seongnam-si, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Seoul, South Korea

  • Research Site, Suwon, South Korea

  • Research Site, Suwon, South Korea

  • Research Site, A Coruña, Spain

  • Research Site, Alicante, Spain

  • Research Site, Barcelona, Spain

  • Research Site, Barcelona, Spain

  • Research Site, Córdoba, Spain

  • Research Site, Madrid, Spain

  • Research Site, Majadahonda, Spain

  • Research Site, Málaga, Spain

  • Research Site, Reus, Spain

  • Research Site, Seville, Spain

  • Research Site, Terrassa, Spain

  • Research Site, Valencia, Spain

  • Research Site, Liuying, Taiwan

  • Research Site, New Taipei City, Taiwan

  • Research Site, Tainan, Taiwan

  • Research Site, Taipei, Taiwan

  • Research Site, Taipei, Taiwan

  • Research Site, Ankara, Turkey (Türkiye)

  • Research Site, Ankara, Turkey (Türkiye)

  • Research Site, Ankara, Turkey (Türkiye)

  • Research Site, Istanbul, Turkey (Türkiye)

  • Research Site, Izmir, Turkey (Türkiye)

Study leads

  • Tina Cascone, MD

    Principal Investigator

    MD Anderson Cancer Center Houston, TX 77030

View source on ClinicalTrials.gov(opens in a new tab)